Seagen Inc. - Common Stock (NQ:SGEN)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 13, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Seagen Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Week In Review: Livzon In-Licenses GERD Therapy In $127 Million Agreement ↗

March 18, 2023

Livzon Pharmaceutical Group entered a $127.5 million agreement for China rights to a gastroesophageal reflux disease therapy from Onconic Therapeutics. Meanwhile, Gracell Biotech announced that it had...

Via Talk Markets

MarketBeat Week in Review – 3/13 - 3/17

March 18, 2023

The first triple witching day of 2023 is a fitting way to end a wild week. As you take some time to relax, here are some of our most popular stories this week

Via MarketBeat

Topics ETFs Economy

Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review ↗

March 17, 2023

A market rally is underway, but bank stocks kept tumbling.

Via Investor's Business Daily

This Must-Buy Dividend Growth Stock Could Pay You for Life ↗

March 16, 2023

It might not regularly beat the market, but it won't have any trouble padding your wallet.

Via The Motley Fool

Here's How Much You Would Have Made Owning Seagen Stock In The Last 5 Years ↗

March 15, 2023

Via Benzinga

A Bullish Sign Appears On Seagen's Chart ↗

March 14, 2023

Via Benzinga

Seagen Inc. (NASDAQ: SGEN) Climbs to New 52-Week High

March 13, 2023

Via Investor Brand Network

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 16, 2023

It's time for another dive into the biggest pre-market stock movers as we go over all the latest news for Thursday morning!

Via InvestorPlace

Pfizer’s Latest Acquisition Strengthens the Case for PFE Stock

March 15, 2023

Pfizer's merger with Seagen will strengthen the company's already strong oncology portfolio and perhaps boost the case for owning PFE stock

Via MarketBeat

Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023 ↗

March 15, 2023

Via Benzinga

Why Seagen Stock Is Soaring Today ↗

March 13, 2023

Investors are cheering Pfizer's planned acquisition of Seagen.

Via The Motley Fool

Check Out What Whales Are Doing With SGEN ↗

March 13, 2023

Via Benzinga

Drug Companies Raising Prices Greater Than Inflation? US Government Mulling Imposing Fines ↗

March 15, 2023

Under Joe Biden's signature Inflation Reduction Act, drugmakers for twenty-seven drugs will be penalized for charging prices that rise faster than inflation for people with disabilities or the elderly...

Via Benzinga

Meta Platforms To Rally Over 36%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

March 15, 2023

Credit Suisse cut the price target for Zscaler, Inc. (NASDAQ: ZS) from $275 to $165. Credit Suisse analyst Sami Badri maintained an Outperform rating. Zscaler shares fell 1.9% to $105.95 in pre-market...

Via Benzinga

Seagen to Present New Clinical and Preclinical Data From Broad Portfolio of Targeted Cancer Therapeutics at the 2023 AACR Annual Meeting

March 14, 2023

From Seagen Inc.

Via Business Wire

Does This Billion-Dollar Deal Solve Pfizer's Biggest Problem? ↗

March 14, 2023

Pfizer's planned acquisition of Seagen could be a very important move.

Via The Motley Fool

Seagen Unusual Options Activity For March 13 ↗

March 13, 2023

Via Benzinga

Key Inflation Meter Doesn't Show New Signs for Concern and Stocks Begin Shaking Off Instability ↗

March 14, 2023

(Tuesday Market Open) The first of this week’s three critical data releases, February’s Consumer Price Index (CPI), was pretty much in line with expectations Tuesday, perhaps easing some concerns about...

Via Benzinga

Is Pfizer Stock a Screaming Buy After Its $43 Billion Seagen Acquisition? ↗

March 14, 2023

Pfizer's $43 billion Seagen acquisition is a long-term value-creation strategy.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023 ↗

March 14, 2023

Via Benzinga

These Analysts Boost Price Targets On Seagen Following Acquisition News ↗

March 14, 2023

Pfizer Inc (NYSE: PFE) agreed to acquire Seagen Inc (NASDAQ: SGEN) for $229 in cash per Seagen share for a total enterprise value of $43 billion. Seagen shares jumped 14.5% to close at $197.65 on...

Via Benzinga

Jabil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

March 14, 2023

Raymond James raised the price target for Jabil Inc. (NYSE: JBL) from $84 to $100. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares fell 0.7% to close at $81.35 on...

Via Benzinga

Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines? ↗

March 14, 2023

Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr.

Via Benzinga

SEAGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Seagen Inc. - SGEN

March 13, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners ↗

March 13, 2023

On a volatile market day, companies are still looking for smart combinations.

Via The Motley Fool

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qualtrics (Nasdaq - XM), Seagen Inc. (Nasdaq - SGEN), Provention Bio Inc. (Nasdaq - PRVB), Kimball International, Inc. (Nasdaq – KBAL)

March 13, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

SGEN Stock Alert: Pfizer Buys Seagen in GIANT $43 Billion Deal ↗

March 13, 2023

Seagen (SGEN) stock is taking off on Monday as investors react to a $43 billion acquisition agreement with Pfizer (PFE).

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023 ↗

March 13, 2023

Via Benzinga

Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 13, 2023

Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.

Via Benzinga

Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗

March 13, 2023

U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.